Current pharmacologic treatment of multiple sclerosis symptoms.
Year: 1996
Type: article
Abstract: About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigue, bladder and bowel involvement, neurobehavioral complaints, pain syndromes, dystonic spasms, and tremor and ataxia.
Source: Europe PMC (PubMed Central)
Authors: P B Andersson, D E Goodkin
Institution: University of California, San Francisco
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W201248051